Sindrome.del.Ovario.Poliquistico

Clínica 69
based on a prospective population study
of women. Acta Obstet Gynecol Scand.
1992;71:599-604.
14
Van Hooff MH, Voorhorst FJ, Kaptein MB,
Hirasing RA, Koppenaal C, Schoemaker
J. Endocrine features of polycystic ovary
syndrome in a random population sample
of 14-16 year old adolescents. Hum
Reprod. 1999;14:2223-9.
15
Norman RJ, Davies MJ, Lord J, Moran
LJ. The role of lifestyle modification
in polycystic ovary syndrome.Trends
Endocrinol Metab. 2002;13:251-7.
16
Hardiman P, Pillay OS, Atiomo W. Polycystic
ovary syndrome and endometrial
carcinoma. Lancet. 2003;361:1810-2.
17
Dagogo-Jack S, Al-Ali N, Qurttom M.
Augmentation of bone mineral density
in hirsute women. J Clin Endocrinol
Metab. 1997;82:2821-5.
18
Carmina E, Chu MC, Longo RA, Rini
GB, Lobo RA. Phenotypic variation in
hyperandrogenic women influences
the findings of abnormal metabolic and
cardiovascular risk parameters. J Clin
Endocrinol Metab. 2005;90:2545-9.
19
Goldzieher JW. Polycystic ovarian disease.
Fertil Steril 1981;35:371-94.
20
Balen AH, Michelmore K. What is polycystic
ovary syndrome? Are national
views important? Hum Reprod. 2002;
17:2219-27.
21
Birch RA, Padmanabhan V, Foster DL,
Unsworth WP, Robison JE. Prenatal
programming of reproductive neuroendocrine
function: fetal androgen exposure
produces progressive disruption
of reproductive cycles in sheep. Endocrinology.
2003;144:1426-34.
22
Abbott DH, Dumesic DA, Franks S.
Developmental origin of polycystic ovary
syndrome: a hypothesis. J Endocrinol.
2002;174:1-5.
23
Baumann EE, Rosenfield RL. Polycystic
ovary syndrome in adolescence. The
Endocrinologist 2002;12:333-48.
24
Mather KJ, Kwan F, Corenblum B.
Hyperinsulinemia in polycystic ovary
syndrome correlates with increased cardiovascular
risk independent of obesity.
Fertil Steril. 2000;73:150-6.
25
Cibula D, Cífková R, Fanta M, Poledne
R, Zivny J, Skibová J. Increased risk
of non-insulin dependent diabetes mellitus
arterial hypertension and coronary
artery disease in perimenopausal
women with a history of the polycystic
ovary syndrome. Hum Reprod. 2000;15:
785-9.
26
Nestler JE. Should patients with polycystic
ovarian syndrome be treated with
metformin?: an enthusiastic endorsement.
Hum Reprod. 2002;17:1950-3.
27
Christian RC, Dumesic DA, Behrenbeck
T, Oberg AL, Sheedy II PF, Fitzpatrick
LA. Prevalence and predictors of coronary
artery calcification in women with
polycystic ovary syndrome. J Clin Endocrinol
Metab. 2003;88:2562-8.
28
Elting MW, Korsen TJM, Bezemer PD,
Schoemaker J. Prevalence of diabetes
mellitus, hypertension and cardiac complaints
in a follow-up study of a Dutch
PCOS population. Hum Reprod. 2001;16:
556-60.
29
Glueck CJ, Wang P, Goldenberg N, Sieve-
Smith L. Pregnancy outcomes among
women with polycystic ovary syndrome
treated with metformin. Hum Reprod.
2002;17:2858-64.
30
Jakubowicz D, Iuorno M, Jakubowicz
S, Roberts KA, Nestler JE. Effects of
metformin on early pregnancy loss in
the polycystic ovary syndrome. J Clin
Endocrinol Metab. 2002;87:524-9.
31
Li TC, Makris M, Tomsu M, Tuckerman
E, Laird E. Recurrent miscarriage: aetiology,
management and prognosis. Hum
Reprod. Update. 2002;8:463-81.
32
Ben-Haroush A, Yogev Y, Hod M. Epidemiology
of gestational diabetes mellitus
and its association with Type 2 diabetes.
Diabet Med. 2004b;21:103-13.
33
Mikola M, Hiilesmaa V, Halttunen M,
Suhonen L, Tiitinen A. Obstetric outcome
in women with polycystic ovar-